This documentation is a presentation (the undertake or agree to update this Presentation or uncertainties and other factors which may cause available industry sources as well as from market “Presentation”) of general background information to correct any inaccuracies in, or omissions from, the actual results, performance or achievements of research and industry analysis and on about DOJA Cannabis Company Ltd.’s (“DOJA” or this Presentation that may become apparent. No DOJA to be materially different from any future assumptions based on data and knowledge of this “the Company”). It is information in a summary person has been authorized to give any results, performance or achievements expressed industry which management believes to be form and does not purport to be complete. It is not information or make any representations other or implied by the forward-looking statements. reasonable. However, this data is inherently intended to be relied upon as advice to investors than those contained in this Presentation and, if These risks, uncertainties and other factors imprecise, although generally indicative of relative or potential investors and does not take into given and/or made, such information or include, but are not limited to risks associated with market positions, market shares and performance account the investment objectives, financial representations must not be relied upon as having general economic conditions; adverse industry characteristics. While management is not aware of situation or needs of any particular investor. These been so authorized. The information and opinions events; marketing costs; loss of markets; future any misstatements regarding any industry data should be considered, with or without professional contained in this Presentation are provided as at legislative and regulatory developments involving presented herein, industry data is subject to advice, when deciding if an investment is the date of this Presentation. The contents of this medical marijuana; inability to access sufficient change based on various factors. appropriate. Presentation are not to be construed as legal, capital from internal and external sources, and/or This Presentation may not be reproduced, further financial or tax advice. Each prospective investor inability to access sufficient capital on favourable This Presentation does not constitute or form part distributed or published in whole or in part by any should contact his, her or its own legal adviser, terms; the medical marijuana industry in Canada of any offer for sale or solicitation of any offer to other person. Neither this Presentation nor any independent financial adviser or tax adviser for generally, income tax and regulatory matters; the buy or subscribe for securities nor shall it or any copy of it may be taken or transmitted into or legal, financial or tax advice. ability of DOJA to implement its business part of it form the basis of or be relied on in distributed in any other jurisdiction which prohibits strategies; competition; crop failure; currency and connection with, or act as any inducement to enter Certain statements in this Presentation may the same except in compliance with applicable interest rate fluctuations, and the other risks. The into, any contract or commitment whatsoever. constitute forward-looking information, including laws. Any failure to comply with this restriction may foregoing factors are not intended to be Recipients of this Presentation who are future-oriented financial information and financial constitute a violation of applicable securities law. exhaustive. Although DOJA has attempted to considering acquiring securities of DOJA are outlooks, within the meaning of applicable Recipients are required to inform themselves of, identify important factors that could cause actual reminded that any such purchase or subscription securities laws. Forward looking information may and comply with, all such restrictions or actions, events or results to differ materially from must not be made on the basis of the information relate to DOJA’s future outlook and anticipated prohibitions and DOJA does not accept liability to those described in forward-looking statements, contained in this Presentation but are referred to events or results and may include statements any person in relation thereto . there may be other factors that cause actions, the entire body of publicly disclosed information regarding DOJA’s financial results, future financial events or results to differ from those anticipated, regarding DOJA. position, expected growth of cash flows, business estimated or intended. Forward-looking strategy, budgets, projected costs, projected statements contained herein are made as of the The information contained in this Presentation is capital expenditures, taxes, plans, objectives, date hereof and DOJA and its directors, officers derived solely from management of DOJA and potential synergies, industry trends and growth and employees disclaim any obligation to update otherwise publicly available information opportunities. Often but not always, forward- any forward-looking statements, whether as a concerning DOJA and does not purport to be all- looking information can be identified by the use of result of new information, future events or results inclusive or to contain all the information that an words such as “anticipate”, “believe”, “expect”, or otherwise. There can be no assurance that investor may desire to have in evaluating whether “project”, “estimate”, “likely”, “intend”, “should”, forward-looking statements will prove to be or not to make an investment in DOJA. The “could”, “may”, “might”, “target”, “plan” and other accurate, as actual results and future events could information has not been independently verified similar expressions or variations (including differ materially from those anticipated in such and is subject to material updating, revision and negative variations) of such words and phrases. statements. Accordingly, you should not place further amendment, and is qualified entirely by Forward-looking information contained in this undue reliance on forward-looking statements due reference to DOJA’s publicly disclosed Presentation is based on certain assumptions to the inherent uncertainty therein. All forward- information. No representation or warranty, regarding expected growth, results of operations, looking information is expressly qualified in its express or implied, is made or given by or on performance, industry trends and growth entirety by this cautionary statement. behalf of DOJA or any of its affiliates, directors, opportunities. officers or employees as to the accuracy, Forward-looking information and other information completeness or fairness of the information or While management considers these assumptions contained herein concerning management’s opinions contained in this Presentation and no to be reasonable, based on information available, general expectations concerning the medical responsibility or liability is accepted by any person they may prove to be incorrect. Forward-looking marijuana industry are based on estimates for such information or opinions. DOJA does not statements involve known and unknown risks, prepared by management using data from publicly
INVESTMENT HIGHLIGHTS DOJA will feature a range of curated handcrafted strains DOJA’s wholly owned subsidiary Northern Lights Marijuana ideally suited for Canada’s emerging cannabis market. Company received its license to cultivate under the ACMPR* on June 16 th , 2017. Kelowna, British Columbia’s world class wineries, lakes, orchards, golf courses and ski hills draw 1.9 million visitors DOJA is the first Licenced Producer to focus exclusively on annually – DOJA will leverage the tourism to the area to build building a cannabis lifestyle brand – “lifestyle” is where DOJA a far-reaching brand believes the medicinal and recreational market meet. The Government of Canada is targeting July 1, 2018 as the CEO Trent Kitsch founded and built SAXX Underwear into official start to a legalized recreational cannabis market – the fastest growing premium men’s underwear brands in Deloitte estimates the base retail market at $4.9 to $8.7 North America; plan to combine expertise in branded billion on demand of 655,000 kg/yr consumer packaged goods with authentic passion for cannabis culture to uniquely position DOJA as a market leading lifestyle brand in the cannabis industry. We expect to reach multiple value creating milestones in the next 12 months
A BIT OF OUR HISTORY DOJA becomes applicant 247 to DOJA successfully advanced past the Received notification that Health Purchased the land and 7,100 become a Licensed Producer under security clearance stage Canada will prepare to request a pre- square foot commercial building the Marijuana for Medical Purposes license inspection upon confirmation associated with its ACMPR Regulations, now the ACMPR from DOJA its proposed site meets application. the ACMPR requirements Health Canada conducted a Pre- DOJA’s wholly owned subsidiary Completed Phase I build-out and Commenced the Phase I build-out of License Inspection of DOJA’s West Northern Lights Marijuana requested a pre-license inspection from a state-of-art-facility, consistent Kelowna facility on May 2nd, 2017. Company received its license to Health Canada with ACMPR standards, capable of cultivate on June 16th, 2017 producing 650 kilograms annually
Recommend
More recommend
